Immuneering Corporation (IMRX)
IMRX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$3.56
-7.77% on the day
Market cap
$230.3M
Micro cap
Revenue · 2023
$0
No prior year to compare
Net income · 2023
-$53.5M
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2023.
Profile
| Field | Value |
|---|---|
| Ticker | IMRX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001790340 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2023
| Line | Value |
|---|---|
| Revenue | $0 |
| Net income | -$53.5M |
| Operating income | -$58.4M |
| Net margin | Needs revenue and net income |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | $59.4M |
| Total assets | $102.6M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | Needs market cap and revenue |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2025-09-25 |
| Latest annual report | 10-K | 2026-03-06 |
| Latest quarterly / interim | 10-Q | 2026-08-05 |
| Latest current report | 8-K | 2026-08-05 |
| Latest proxy | DEFA14A | 2026-04-20 |
Source: SEC EDGAR submissions feed, 320 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| IFRX | InflaRx N.V. | $1.55 | -2.52% | $228.4M |
| GLSI | Greenwich LifeSciences Inc. | $15.50 | -12.77% | $227.5M |
| ZNTL | Zentalis Pharmaceuticals Inc. | $2.40 | -4.76% | $227.2M |
| NATR | Nature's Sunshine Products Inc. | $12.76 | +0.39% | $224.5M |
| LRMR | Larimar Therapeutics Inc. | $2.16 | -14.63% | $224.4M |
| BBOT | BridgeBio Oncology Therapeutics Inc. Common Stock | $2.95 | -9.51% | $236.5M |
| SLGL | Sol-Gel Technologies Ltd. | $68.30 | -5.66% | $223.6M |
| KROS | Keros Therapeutics Inc. | $11.23 | -3.27% | $222.7M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier